Repository logo
 

Human cell transformation by combined lineage conversion and oncogene expression.

Published version
Peer-reviewed

Change log

Authors

Abstract

Cancer is the most complex genetic disease known, with mutations implicated in more than 250 genes. However, it is still elusive which specific mutations found in human patients lead to tumorigenesis. Here we show that a combination of oncogenes that is characteristic of liver cancer (CTNNB1, TERT, MYC) induces senescence in human fibroblasts and primary hepatocytes. However, reprogramming fibroblasts to a liver progenitor fate, induced hepatocytes (iHeps), makes them sensitive to transformation by the same oncogenes. The transformed iHeps are highly proliferative, tumorigenic in nude mice, and bear gene expression signatures of liver cancer. These results show that tumorigenesis is triggered by a combination of three elements: the set of driver mutations, the cellular lineage, and the state of differentiation of the cells along the lineage. Our results provide direct support for the role of cell identity as a key determinant in transformation and establish a paradigm for studying the dynamic role of oncogenic drivers in human tumorigenesis.

Description

Funder: Syöpäsäätiö (Cancer Foundation Finland); doi: https://doi.org/10.13039/501100010711


Funder: Sigrid Juséliuksen Säätiö (Sigrid Jusélius Foundation); doi: https://doi.org/10.13039/501100006306


Funder: Jane ja Aatos Erkon Säätiö (Jane and Aatos Erkko Foundation); doi: https://doi.org/10.13039/501100004012


Funder: iCAN Digital Precision Cancer Medicine Flagship


Funder: Finska Läkaresällskapet (Medical Society of Finland); doi: https://doi.org/10.13039/100010135


Funder: Helsingin ja Uudenmaan Sairaanhoitopiiri (Helsinki University Central Hospital); doi: https://doi.org/10.13039/100008376


Funder: iCAN Digital Precision Cancer Medicine Flagship (grant number 320185)

Keywords

Animals, Cell Differentiation, Cell Transformation, Neoplastic, Humans, Mice, Proto-Oncogenes, Translocation, Genetic

Journal Title

Oncogene

Conference Name

Journal ISSN

0950-9232
1476-5594

Volume Title

40

Publisher

Springer Science and Business Media LLC
Sponsorship
European Commission Horizon 2020 (H2020) Research Infrastructures (RI) (667403)